Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 57.26
-1.30 (-2.22%)
Apr 30, 2026, 9:55 AM CST
SHA:688621 Revenue
Beijing Sun-Novo Pharmaceutical Research had revenue of 197.10M CNY in the quarter ending March 31, 2026, a decrease of -14.62%. This brings the company's revenue in the last twelve months to 1.19B, up 12.44% year-over-year. In the year 2025, Beijing Sun-Novo Pharmaceutical Research had annual revenue of 1.22B with 13.33% growth.
Revenue (ttm)
1.19B
Revenue Growth
+12.44%
P/S Ratio
5.38
Revenue / Employee
763.82K
Employees
1,359
Market Cap
6.40B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hunan Jiudian Pharmaceutical | 3.01B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| ChengDa Pharmaceuticals | 406.37M |
| Jinghua Pharmaceutical Group | 1.46B |
| Shandong Wit Dyne Health | 2.02B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| Hainan Haiyao | 831.18M |